The first daily disposable silicone hydrogel soft contact lenses specifically designed for slowing the progression of myopia in children*1 are launching soon in Australia, Johnson & Johnson (J&J) Vision has announced.
ACUVUE Abiliti 1-Day Soft Therapeutic Lenses for Myopia Management are described as a “breakthrough innovation with proven efficacy”‡1 that have been shown to be ~2x as effective at managing myopia compared to a dual focus lens,§˄2 according to the manufacturer.
Furthermore, they have been shown to slow axial elongation by 0.25mm, on average, over a two-year period.¥2
This is due to J&J’s novel RingBoost technology that the company says maximises treatment strength while focusing rays off the line of sight, allowing the lens to be built with stronger treatment power while maintaining vision quality.
In fact, the company said more than 95% of children wearing ACUVUE Abiliti 1-Day achieved visual acuity 6/6 or better.†3
“Breaking down many of the barriers that stand in the way of children receiving the full benefit of myopia control, Abiliti 1-Day Lenses are designed for the paediatric eye,” J&J said in a statement.
“They have a smaller diameter for improved insertion and removal, and provide the comfort you expect from ACUVUE OASYS 1-Day contact lenses.¶3 When compared to spectacles, wearing contact lenses boosted self confidence4,5 in kids, and improved school and sports performance.”4,5
J&J plans to officially introduce Abiliti 1-Day to Australia on 18 August 2025 at the Optometry Clinical Conference (OCC) in Melbourne. Registration is now open for an introductory webinar for Abiliti 1-Day held a few days later on 20 August, featuring globally renowned researchers and expert clinicians, Associate Profssor Noel Brennan, Dr Xu Cheng and optometrist Mr Alex Petty.
Meanwhile, practices that would like to take the first step towards accessing Abiliti 1-Day can complete the ACUVUE Abiliti 1-Day Accreditation Program (AU) on JNJVISIONPRO.
More reading
Australian optometrists give early insights on ACUVUE Abiliti 1-Day for myopia control
Myopia – will Australia sink or swim in surging global wave?
Playing it safe: integrating UV safety with myopia control
Disclaimers and references
* Based on publicly available information as of December 3, 2021.
‡ Specifically targeted and designed for slowing the progression of myopia in children.
§ Based on axial elongation after 6 months of wear.
˄ Senofilcon A prototype dual focus lens.
¥ Compared to a single vision contact lens after 2 years of wear.
† Measured using LogMAR visual acuity where 0.00 LogMAR is equivalent to 20/20 vision.
¶ ACUVUE® Abiliti® 1-Day Soft Therapeutic Lenses for Myopia Management are manufactured using senofilcon A, the same material used to manufacture ACUVUE® OASYS 1-Day contact lenses.
1. JJV Data on file, 2021. Development of Optical Design of ACUVUE® Abiliti® 1-Day Soft Therapeutic Lenses for Myopia Management.
2. JJV Data on file, 2021. Efficacy of ACUVUE® Abiliti® 1-Day Soft Therapeutic Lenses for Myopia Management: Comparative Claims vs. Single Vision and Dual Focus Lenses.
3. JJV Data on File 2021. Stand-Alone Performance Claims – ACUVUE Abiliti 1-Day Soft Therapeutic Lenses for Myopia Management.
4. Rah MJ, et al; ACHIEVE Study Group. Vision specific quality of life of pediatric contact lens wearers. Optom Vis Sci. 2010 Aug;87(8):560-6.
5. Walline JJ,et al. Benefits of contact lens wear for children and teens. Eye Contact Lens. 2007 Nov;33(6 Pt 1):317-21.
